[Retracted] Analysis of Clinical Characteristics and Risk Factors of Postoperative Recurrence and Malignant Transformation of Low-Grade Glioma

Figure 3

Expression of related proteins in primary, recurrent, and malignant transformed gliomas (SP400×). Note: a1, a2, b1, b2, c1, c2, e1, e2, f1, f2, g1, g2, and h1, h2 are the levels of PCNA, MMP-9, OY-TES-1, P53, MDM2, VEGF, and EGFR in primary and malignant transforming gliomas, respectively. d is the positive expression of OY-TES-1 mRNA, where 1 is DNA marker, 2 is testicular cDNA (positive control), 3 is positive expression of OY-TES-1 mRNA in primary glioma tissues, and 4–6 are positive expression of OY-TES-1 mRNA in recurrent and MTF glioma tissues.